CVS Health CorpCVS
Price$85.20Intrinsic value$78.698% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $415.1B+11.3% YoYTTM through 30 Jun 2026
Net Income $4.9B+6.0% YoYTTM through 30 Jun 2026
Free Cash Flow $11.8BTTM through 30 Jun 2026

Margins

Current
EBITDA Margin3.1%
Operating Margin2.0%
Net Margin1.2%

Returns

6.1%ROE
1.9%ROA
3.7%ROIC

Balance Sheet Health

Debt / Equity0.80x
Current Ratio0.87x
Net Debt$52.4B
Cash & Equivalents$11.3B

Quality Metrics

Altman Z-Score2.43
Piotroski F-Score5 / 9
FCF Margin2.8%
Rule of 403.5
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $402.1B
Diluted EPS$3.79TTM
'19'20'21'22'23'24'25
FY2025: $1.39

Dividend

$1.33Per share, FY20261.53%Yield-7.8%5-yr growth

Capital Allocation

Capex Intensity0.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.